Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke

Conditions: Ischemic Stroke, Acute; Diabetes Mellitus, Type 2; Blood Brain Barrier Interventions: Drug: Cerebrolysin; Procedure: Brain-MRI with contrast after 10-14 days of cerebrolysin Sponsors: Hospital Universitario Dr. Jose E. Gonzalez; Ever Neuro Pharma GmbH Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials